We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+12.07%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$1.23B
AUM Growth
+$191M
Cap. Flow
+$102M
Cap. Flow %
8.28%
Top 10 Hldgs %
30.7%
Holding
101
New
8
Increased
39
Reduced
39
Closed
6

Top Buys

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$18.2M
2
EXAS
Exact Sciences
EXAS
+$18.1M
3
MDT icon
Medtronic
MDT
+$13.5M
4
NVO
Novo Nordisk
NVO
+$13.3M
5
APLS
Apellis Pharmaceuticals
APLS
+$11.6M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$18.9M
2
UNH icon
UnitedHealth
UNH
+$18.4M
3
CI icon
Cigna
CI
+$11.2M
4
OSCR icon
Oscar Health
OSCR
+$9.64M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$9.15M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUGX
101
DELISTED
Augmedix, Inc. Common Stock
AUGX
– –
-1,000,000
Closed -$880K
1 2 3 4
5

Similar funds

ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return
AF
Ally Financial Detroit, Michigan $804M AUM 0.18% 1-Year Est. Return

Rhenman & Partners Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Rhenman & Partners Asset Management held 101 positions worth $1.23B, up 18% from $1.04B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Rhenman & Partners Asset Management deployed $102M of net new capital in Q3 2024, opening 8 new positions and adding to 39 existing holdings. Its largest new stake was Novo Nordisk: 100,000 shares worth $11.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Elevance Health, an estimated $18.9M trimmed.

  • Rhenman & Partners Asset Management's largest Q3 2024 buy was Novo Nordisk: 100,000 shares worth $11.9M.
  • Rhenman & Partners Asset Management added most to Inspire Medical Systems in Q3 2024, an estimated $18.2M increase.
  • Rhenman & Partners Asset Management's biggest Q3 2024 reduction was Elevance Health, cutting an estimated $18.9M.
  • Rhenman & Partners Asset Management fully exited Edwards Lifesciences in Q3 2024, selling an estimated $9.01M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 31% of its $1.23B portfolio in Q3 2024.
  • Rhenman & Partners Asset Management opened 8 new positions and closed 6 in Q3 2024.
  • Rhenman & Partners Asset Management's portfolio value rose 18% quarter-over-quarter to $1.23B.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.